Journal: EMBO Reports
Article Title: Human PC4 supports telomere stability and viability in cells utilizing the alternative lengthening of telomeres mechanism
doi: 10.1038/s44319-024-00295-3
Figure Lengend Snippet: Reagents and tools table
Article Snippet: Primary antibodies were: a rabbit polyclonal anti-PC4 (same as above, 1:5000 dilution), a rabbit polyclonal anti-RPA32 pSer33 (same as above, 1:2000 dilution), a rabbit polyclonal anti-RPA32 (Bethyl Laboratories, A300-244A; 1:2000 dilution), a mouse monoclonal anti-beta Actin (Abcam, ab8224; 1:5000 dilution), a rabbit polyclonal anti-PML (same as above, 1:1000 dilution), a rabbit polyclonal anti-TRF2 (Novus Biologicals, NB110-57130; 1:1000 dilution), a rabbit monoclonal anti-Vinculin (Cell Signaling Technology, #13901; 1:1000 dilution), a rabbit polyclonal anti-Bloom (Bethyl Laboratories, A300-110A; 1:1000 dilution), a rabbit polyclonal anti-ATRX (Bethyl Laboratories, A301-045A; 1:1000 dilution), a rabbit polyclonal anti-RNA PolII (Bethyl Laboratories, A300-653A; 1:2000 dilution), a rabbit polyclonal anti-phospho RNA PolII (S2) (Bethyl Laboratories, A300-654A; 1:10000 dilution), a rabbit polyclonal anti-phospho RNA PolII (S5) (Bethyl Laboratories, A300-655A; 1:10000 dilution), and a goat polyclonal anti-Helic2 (Santa Cruz Biotechnology, SC-68563; 1:1000 dilution).
Techniques: In Vitro, Recombinant, shRNA, Control, Plasmid Preparation, Sequencing, Negative Control, Magnetic Beads, Protease Inhibitor, Blocking Assay, Software, Microscopy